AGF U.S. Market Neutral Anti-Beta Fund (BTAL)

The AGF U.S. Market Neutral Anti-Beta Fund primarily employs a strategy of purchasing shares of less volatile American companies (those with low beta) while simultaneously establishing short positions in more volatile U.S. equities (high beta stocks). This is done on a sector-by-sector basis, with the objective of maintaining a dollar-neutral portfolio where the value of long and short investments is balanced. The fund constructs this balanced portfolio predominantly by allocating capital to the same securities that comprise the Dow Jones U.S. Thematic Market Neutral Low Beta Index, generally matching their respective weightings within that index. The selection pool for this underlying index encompasses the top 1,000 eligible U.S. securities ranked by market capitalization, a universe that also includes Real Estate Investment Trusts (REITs).